ANTIOXIDANT THERAPY FOR DRY EYE DISEASE: A SYSTEMATIC REVIEW DOI Open Access

S. Harini,

Sai Mohan,

V. Chitra

et al.

International Journal of Biology Pharmacy and Allied Sciences, Journal Year: 2023, Volume and Issue: 12(10 (SPECIAL ISSUE))

Published: Oct. 12, 2023

This systematic review highlights the potential of antioxidants as therapeutic intervention in dry eye disease.Preclinical reports assessing effect plant based and synthetic against disease was collected from online electronic databases like Scopus, PubMed, Science direct, DOAJ, Jgate.The protocol registered on PROSPERO, registration no.CRD42023420934.The followed PRISMA approach for including all were appraised risk bias using SYRCLE's RoB tool.From search results 26 articles met inclusion criteria review.These analyzed rodent species strain used, which improved tear volume, restore conjunctival goblet cells, amelioration inflammatory cytokines TNF-α, IL-1β, NLRP3 reduction oxidative stress.The studies reported this insinuates target their mechanism action stress, corneal irregularity, ocular surface inflammation apoptosis secretion.These repots compositely suggest that can ameliorate negative effects improve secretion to maintain homeostasis.

Language: Английский

Conditioned media of stem cells from human exfoliated deciduous teeth contain factors related to extracellular matrix organization and promotes corneal epithelial wound healing DOI
Shinri Sato, Yuji Teramura, Yoko Ogawa

et al.

Regenerative Therapy, Journal Year: 2025, Volume and Issue: 29, P. 148 - 161

Published: March 18, 2025

Language: Английский

Citations

0

Exosomes-based dual drug-loaded nanocarrier for targeted and multiple proliferative vitreoretinopathy therapy DOI Creative Commons
Peiyi Zhao, Jiahao Wang, Huiying Huang

et al.

Regenerative Biomaterials, Journal Year: 2024, Volume and Issue: 11

Published: Jan. 1, 2024

Abstract Proliferative vitreoretinopathy (PVR) is a common cause of vision loss after retinal reattachment surgery and ocular trauma. The key pathogenic mechanisms PVR development include the proliferation, migration epithelial-mesenchymal transition (EMT) pigment epithelial cells (RPEs) activated by growth factors cytokines surgery. Although some drugs have been tried in treatments as basic investigations, limited efficacy remains an obstacle, which may be due to single pharmacological action lack targeting. Herein, anti-proliferative Daunorubicin anti-inflammatory Dexamethasone were co-loaded RPEs-derived exosomes (Exos), obtaining Exos-based dual drug-loaded nanocarrier (Exos@D-D), used for multiple therapy. Owing advantages homologous Exos drug loading, Exos@D-D showed good RPEs targeting well improved uptake efficiency, could inhibit migration, EMT effectively. animal studies also demonstrated that effectively inhibits production proliferative membranes prevents further inflammation, shows significant therapeutic effects on biocompatibility. Such investigation not only provides promising approach multifunctional exosome delivery systems construction, but has great potential clinical therapy application.

Language: Английский

Citations

3

Nanomedicines for Dry Eye Syndrome: Targeting Oxidative Stress with Modern Nanomaterial Strategies DOI Creative Commons
Aleksandra Krawczyk,

Sara Marta Stadler,

Barbara Strzałka‐Mrozik

et al.

Molecules, Journal Year: 2024, Volume and Issue: 29(16), P. 3732 - 3732

Published: Aug. 7, 2024

Dry eye syndrome (DES) is a dynamic, chronic disease of the ocular surface and appendages caused by inflammation. The most common symptoms include redness, itching, blurred vision, resulting from dysfunction meibomian glands impaired tear-film production. Factors contributing to development DES environmental elements, such as UV radiation, internal hormonal imbalances. These factors increase oxidative stress, which exacerbates inflammation on accelerates DES. In recent years, incidence has risen, leading greater need develop effective treatments. Current treatments for dry are limited primarily focus alleviating individual symptoms, reducing surface. However, it crucial understand pathomechanism tailor treatment address underlying causes achieve best possible therapeutic outcomes. Therefore, in this review, we analyzed impact stress gain better understanding its examined recently developed nanosystems that allow drugs be delivered directly site.

Language: Английский

Citations

3

Cerium Oxide Nanoparticle-Papain Enzyme Bioconjugate: Synthesis, Characterization and Optical Absorption Study for Biomedical Applications DOI Open Access
Goutam Mandal, Baibaswata Bhattacharjee

Indian Journal of Science and Technology, Journal Year: 2024, Volume and Issue: 17(13), P. 1331 - 1339

Published: March 25, 2024

Objective: Here, we synthesize cerium oxide nanoparticles, successfully characterize them, and study the interaction between enzymes nanoparticles (CeO2 NPs) using a simple optical spectroscopic technique. Method: CeO2 was fabricated by chemical method. Characterizations were done UV-Vis absorption spectra, FESEM images, XRD data. For biomolecular study, papain used as model enzyme. Two different concentrations of CeO2, namely small concentration range (0.05810 to 0.40670 mM) large (0.58100 0.92961 mM), taken with papain. spectra recorded bioconjugate formation. Findings: The NPs have an intense peak at 352 nm band gap 3.78 eV. pattern showed unit cell is cubic average particle size 41.36 nm. binding resulted in red shift its peak. apparent association constant (Kapp) calculated for found be 0.747 × 103 M-1 0.278 concentrations. In concentrations, aggregation occurs instead corona Novelty: To best our knowledge, this may first enzyme NPs. This contributes application field biomedicine. Keywords: Cerium oxide, Papaya proteinase (PP), Absorption Bioconjugate, Association

Language: Английский

Citations

2

Multifunctional Cerium Oxide Nanozyme for Synergistic Dry Eye Disease Therapy DOI

Haoyu Zou,

Yueze Hong,

Baoqi Xu

et al.

ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(27), P. 34757 - 34771

Published: July 1, 2024

Dry eye disease (DED) is a chronic multifactorial ocular surface mainly caused by the instability of tear film, characterized series discomforts and even visual disorders. Oxidative stress has been recognized as an upstream factor in DED development. Diquafosol sodium (DQS) agonist P2Y2 receptor to restore integrity/stability film. With ability alternate between Ce3+ Ce4+, cerium oxide nanozymes could scavenge overexpressed reactive oxygen species (ROS). Hence, DQS-loaded nanozyme was designed boost synergistic treatment DED. Cerium with branched polyethylenimine-graft-poly(ethylene glycol) nucleating agent dispersant fabricated followed DQS immobilization via dynamic phenylborate ester bond, obtaining (defined Ce@PBD). Because mimic cascade processes superoxide dismutase catalase, Ce@PBD excessive accumulated ROS, showing strong antioxidant anti-inflammatory properties. Meanwhile, receptors conjunctival cells be stimulated Ce@PBD, which can relieve incompleteness The animal experiments demonstrated that significantly restored defect corneal epithelium increased number goblet cells, promotion secretion, best among commercial ophthalmic solutions.

Language: Английский

Citations

2

Multifunctional cerium oxide nanozymes with high ocular surface retention for dry eye disease treatment achieved by restoring redox balance DOI

Haoyu Zou,

Yueze Hong,

Baoqi Xu

et al.

Acta Biomaterialia, Journal Year: 2024, Volume and Issue: 185, P. 441 - 455

Published: July 11, 2024

Language: Английский

Citations

2

The emerging role of nanozymes in ocular antioxidant therapy DOI
Xue Bai,

Yu Lu,

Shuyu Wang

et al.

Nano Today, Journal Year: 2024, Volume and Issue: 58, P. 102448 - 102448

Published: Aug. 23, 2024

Language: Английский

Citations

2

NIR-switchable local hydrogen generation by tandem bimetallic MOFs nanocomposites for enhanced chemodynamic therapy DOI Creative Commons
Jun Zhong, Xiang Zheng,

Yuan Wen

et al.

Regenerative Biomaterials, Journal Year: 2023, Volume and Issue: 11

Published: Oct. 31, 2023

Abstract The inadequate quantity of hydrogen peroxide (H2O2) in cancer cells promptly results the constrained success chemodynamic therapy (CDT). Significant efforts made throughout years; nevertheless, researchers are still facing great challenge designing a CDT agent and securing H2O2 supply within tumor cell. In this study, taking advantage level maintenance mechanism cells, nanozyme-based bimetallic metal-organic frameworks (MOFs) tandem reactor is fabricated to elevate intracellular levels, thereby enhancing CDT. addition, under near-infrared excitation, upconversion nanoparticles (UCNPs) loaded into MOFs can perform photocatalysis generate hydrogen, which increases cellular susceptibility radicals induced from H2O2, inhibits cell energy, causes DNA damages induces apoptosis, thus improving therapeutic efficacy synergistically. proposed MOFs-mediated UCNPs-mediated act as combined with high low toxicity.

Language: Английский

Citations

6

Anti-Oxidative Mesoporous Polydopamine-Based Hypotensive Nano-Eyedrop for Improved Glaucoma Management DOI

Yate Huang,

Xiaoxu Ding,

Li Zhu

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2024, Volume and Issue: 245, P. 114261 - 114261

Published: Sept. 19, 2024

Language: Английский

Citations

1

In Situ Crystallized Ceria‐Vesicle Nanohybrid Therapeutic for Effective Treatment of Inflammatory Intraocular Disease DOI Open Access
Jiawei Zhao, Yingjie Wang, Yiquan Zhang

et al.

Advanced Healthcare Materials, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 23, 2024

Abstract Posterior uveitis is a leading cause of vision impairment and blindness globally due to its detrimental effects on the choroid retina. The condition worsened by oxidative stress, which heightens inflammation perpetuates cycle damage that current treatments only temporarily relieve. To address this, novel treatment involving in situ crystallization ultrasmall cerium oxide nanoparticles (≈3 nm) mesenchymal stem cell (MSC) extracellular vesicles (EVs) for management primed mycobacterial (PMU) developed. This nanohybrid leverages individual synergistic components comprehensive therapeutic approach. act as nanozyme reduce scavenge excessive reactive oxygen species (ROS), while MSC EVs, with their biocompatibility, modulate inflammatory infiltration alleviate tissue damage. system offers promising new strategy ocular diseases characterized stress inflammation.

Language: Английский

Citations

1